A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Clinical trial NCT04539548 · COMPLETED
Trial details
- NCT number
- NCT04539548
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2023-12-21
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.